Emcure halves price of its semaglutide weight loss drug Poviztra after Novo Nordisk patent expiry — check new rates

Emcure Pharmaceuticals has reduced the price of its weight management drug Poviztra to ₹3,999 per month, effective 3 April 2026. The move follows increased competition after semaglutide's patent expiration in India. Details here. 

Go to News Site